All of the following are monoclonal antibodies against CD-20 except :: (A) Rituximab, (B) Ofatumumab, (C) Ocrelizumab, (D) Brentuximab
Answer is D. Rituximab, Ofatumumab, Ocrelizumab & Obinutuzumab are monoclonal antibodies against Cd-20.
Brentuximab acts against CD30.